IL13 and non-small cell lung carcinoma: Similarly, S100A9(+) inflammatory monocytes in patients with non-small cell lung cancer (NSCLC) are shown to suppress T-cells by production of arginase, iNOS, and the IL-13/IL-4Rα axis.